Tag: CBT > Descheduling Cannabis: Page 4

Cannabis Rescheduling

US Health and Human Services Department Recommends Cannabis Reclassified to Schedule III

The move from Schedule I to Schedule III would provide that cannabis has a federally accepted medical use, but the decision now goes to the DEA.

August 30, 2023

Interviews & Opinion

Opinion: Rescheduling Is Recriminalizing, Descheduling Is Decriminalizing

President of cannabis genetics company DNA Genetics, Rezwan Khan, weighs in on Biden's cannabis policy reform plan and how rescheduling or descheduling the plant would impact the industry.

August 29, 2023

Advocacy for Cannabis Legalization

Cannabis Advocacy Organizations Press Biden on Policy Reform Ahead of 4/20

A coalition of 85 local, state and national groups sent a letter to President Joe Biden this week urging him and his administration to federally deschedule cannabis.

April 19, 2023

Adult-Use Legalization Bill

After Oklahoma, the Cannabis Industry Eagerly Awaits Legalization Action Elsewhere

Attorneys share their reactions to state legislatures considering legalization, what they make of voters rejecting an adult-use market in Oklahoma, and what it all means for federal policy reform.

March 14, 2023

The Last Word

A Unified National Cannabis Policy

FDA’s new senior public health adviser Norman Birenbaum talks about the agency’s approach to hemp-derived products and cannabis regulation, and what may come next.

March 13, 2023

Hemp Research

Risky Research

January 5, 2023

Legislation and Regulation

29 Lawmakers Urge President to Understand Necessity of Federally Descheduling Cannabis

The letter follows President Joe Biden’s October announcement that directed the Department of Health and Human Services and the Department of Justice to review how cannabis is scheduled.

December 23, 2022

Interviews & Opinion

What’s Next for the Cannabis Industry Following the Midterm Elections?

Cannabis-focused attorneys share their predictions for the newly legalized adult-use markets in Maryland and Missouri, as well as how the federal landscape may shift heading into next year.

November 18, 2022

Legislation and Regulation

US House Members Release Memo on Benefits of Cannabis Decriminalization, Descheduling, Propose Reforms

The U.S. House Oversight Committee’s Subcommittee on Civil Rights and Civil Liberties released the joint memo ahead of a Nov. 15 hearing on cannabis.

November 14, 2022

Legislation and Regulation

Global Alliance for Cannabis Commerce Discusses Federal and State Cannabis Policy Ahead of Congressional Hearing Testimony

GACC leaders Randal John Meyer and Rezwan Khan broke down some of the industry trade group’s approaches and positions on state and federal reform.

November 14, 2022

Legislation and Regulation

To Reschedule or Deschedule? Plant-Touching Businesses Weigh In

Owners and operators of cannabis companies across the U.S. say they would like to see cannabis completely descheduled as a result of President Joe Biden’s order to review cannabis’s status under the Controlled Substances Act.

November 7, 2022

Legislation and Regulation

Biden's Order to Review Cannabis 'Truly Historic,' But What's at Stake?

Many industry experts agree removing cannabis from the list of Controlled Substances would be ideal. But a rescheduling could make things more complex—or even a 'disaster' for the state-legal industry.

October 26, 2022